Brief by Shorts91 Newsdesk / 05:20pm on 09 Apr 2024,Tuesday Health & Wellness
India ranks second globally in hepatitis B and C cases after China, according to the World Health Organization's 2024 Global Hepatitis Report. With over 3.5 lakh cases in 2022, India accounted for 11.6% of the global disease burden that year. Chronic hepatitis B infection contributes to 40-50% of liver cancer cases and 20-30% of cirrhosis cases in India. Despite vaccine availability since 2002, only 2.4% of infected individuals in India have received diagnosis coverage. Urgent action is needed to address the rising mortality rates and improve vaccination coverage to combat the hepatitis epidemic.
